Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.54 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.46 |
| ▸ | CPB2 | Q96IY4 | 12/20 | 0.44 |
| ▸ | GSR | P00390 | 1/20 | 0.42 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30915500 | 0.87 | FOLH1 (0.57) | FOLH1SLC6A5CPB2GSRRNPEP | |
| SCHEMBL29187387 | 0.87 | FOLH1 (0.57) | FOLH1SLC6A5CPB2GSRRNPEP | |
| SCHEMBL13049083 | 0.87 | FOLH1 (0.57) | FOLH1SLC6A5CPB2GSRRNPEP | |
| SCHEMBL18741275 | 0.85 | FOLH1 (0.55) | FOLH1SLC6A5CPB2GSRRNPEP | |
| SCHEMBL29918590 | 0.85 | FOLH1 (0.55) | FOLH1SLC6A5CPB2GSRRNPEP | |
| SCHEMBL18741276 | 0.85 | FOLH1 (0.55) | FOLH1SLC6A5CPB2GSRRNPEP | |
| SCHEMBL22689972 | 0.84 | FOLH1 (0.54) | FOLH1SLC6A5CPB2GSRCA1 | |
| SCHEMBL7165076 | 0.81 | FOLH1 (0.50) | FOLH1SLC6A5CPB2GSRCA1 | |
| SCHEMBL7165072 | 0.81 | FOLH1 (0.50) | FOLH1SLC6A5CPB2GSRCA1 | |
| SCHEMBL7165075 | 0.81 | FOLH1 (0.50) | FOLH1SLC6A5CPB2GSRCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230139680-A1 | A GENETICALLY ENCODED, PHAGE-DISPLAYED CYCLIC PEPTIDE LIBRARY AND METHODS OF MAKING THE SAME | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2023-05-04 | — | — | US | disclosed |
| EP-3972625-A1 | A GENETICALLY ENCODED, PHAGE-DISPLAYED CYCLIC PEPTIDE LIBRARY AND METHODS OF MAKING THE SAME | The Texas A&M University System (US) | 2022-03-30 | — | — | EP | disclosed |
| CN-113727725-A | Genetically encoded phage-displayed cyclic peptide libraries and methods of making the same | 得克萨斯A&M大学系统 | 2021-11-30 | — | — | CN | disclosed |
| WO-2020236146-A1 | A GENETICALLY ENCODED, PHAGE-DISPLAYED CYCLIC PEPTIDE LIBRARY AND METHODS OF MAKING THE SAME | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2020-11-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230139680-A1 | A GENETICALLY ENCODED, PHAGE-DISPLAYED CYCLIC PEPTIDE LIBRARY AND METHODS OF MAKING THE SAME | QPCTL, LNPEP, QPCT | FOLH1 137/4885SLC6A5 2304/4885CPB2 37/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.